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DIFFERENTIAL DIAGNOSIS
The differential diagnosis for ST-elevation includes STEMI, 
aortic dissection, pulmonary embolism, stress  (takotsubo) 
cardiomyopathy, pericarditis with or without effusion, 
myocarditis, hypercalcemia, hyperkalemia, coronary 
vasospasm, coronary artery dissection, left ventricular 
aneurysm, left ventricular hypertrophy, the Brugada 
syndrome, left bundle branch block, early repolarization, 
early post-cardioversion, intracranial hemorrhage, and 
rarely, tumor invasion of the heart 3,4,5,6.
OUTCOME
Because of his hypercalcemia, the patient was administered 
aggressive intravenous (IV) hydration and IV bisphos-
phonates. Given the concern for STEMI, a transthoracic 
echocardiogram was performed immediately which 
showed a 2.4 cm mass involving the epicardium and 
myocardium of the left and right ventricular apices and an 
ejection fraction of 75% without segmental wall motion 
abnormalities (Figures 4 and 5). His serial troponin values 
decreased to 0.09 ng/mL and 0.08 ng/mL over the next 
twelve hours. Cardiology was consulted and deemed that 
given the patient’s history, absence of specific cardiac 
symptoms, prior ST-changes, and echo findings, the EKG 
changes were likely due to metastatic disease rather than 
acute coronary syndrome. One suspected etiology of the 
ST changes was from his significant hypercalcemia. 
However, after resolution of his hypercalcemia, the ST 
elevations persisted on EKG. Interestingly, prior to the 
patient’s diagnosis of metastatic disease, his EKG did not 
show these ST changes (Figure 6). Furthermore, the 
patient’s ST elevations persisted after correction of his 
hypercalcemia. Further workup for his altered mental 
status revealed diffuse brain metastases and a sternal 
wound concerning for infection so he was started on 
broad spectrum antibiotics. Despite optimal medical 
therapy, he had worsening shortness of breath and 
hemodynamic instability. Given his poor prognosis, the 
family and health care providers agreed that a comfort 
care approach would be consistent with his wishes. He 
passed away two weeks after admission.
DISCUSSION
When evaluating for potential acute coronary syndrome in 
the presence of ST-elevation on electrocardiogram, 
myocardial ischemia should always be the first consideration, 
as a delay in providing revascularization can prove 
catastrophic. However, after acute coronary artery occlusion 
or coronary plaque rupture secondary to atherosclerotic 
disease have been ruled out, it is important to consider other 
causes for myocardial injury. Malignancy with metastatic 
involvement of the heart is a rare cause of ST-elevation7.
INTRODUCTION
Heart disease remains the leading cause of mortality in 
the United States, accounting for about one quarter of all 
deaths in 20131. Acute ischemic heart disease is a major 
subpopulation of this group, and typically presents with 
characteristic electrocardiographic (EKG) changes. The 
most concerning of these findings are ST-elevations, as 
ST Elevation Myocardial Infarction (STEMI) typically 
indicates the need for emergent reperfusion therapy 
because 30-day mortality of untreated STEMI is 
approximately 10-15% versus 5% in treated cases2. As a 
result, clinicians are taught to recognize the symptoms 
and signs of myocardial ischemia and STEMI in order to 
achieve timely reperfusion either via thrombolytic therapy 
within 30 minutes or percutaneous coronary intervention 
within 90 minutes.
However, ST-elevations may result from etiologies other 
than acute ischemia, and can be secondary to other 
acutely life-threatening pathologies or relatively benign, 
subacute causes. For example, ventricular aneurysms 
resulting from prior myocardial infarction and pericarditis 
can result in ST-elevation on EKG. Intracranial hemorrhage 
or stress (takotsubo) cardiomyopathy can also present 
with ST-elevations, theorized to be the result of increased 
catecholamines. Left ventricular hypertrophy, a sequela 
of poorly controlled hypertension, can also lead to J point 
elevations mimicking STEMI3,4.
Here we review a case of unusual ST-elevation in a patient 
with oropharyngeal squamous cell carcinoma metastatic 
to the heart.
CASE PRESENTATION
A 55 year old male with a history of hepatitis C cirrhosis, 
hypertension, and squamous cell carcinoma of the 
mouth status post resection and weekly cisplatin/
paclitaxel chemotherapy and postoperative radiation 
therapy to the neck, with known diffuse metastases, 
presented with confusion and generalized weakness. His 
initial physical exam was significant for hyperpigmen-
tation of his neck and decreased breath sounds bilaterally. 
His laboratory values showed hypercalcemia with an 
ionized calcium of 7.4 mg/dL (normal 4.5-5.3 mg/dL). 
Additionally, he was found to have troponin T of 0.10 ng/
mL (normal <0.01 ng/mL) and EKG showed 1 to 5 mm 
ST-elevation in V2-V6 (Figure 1). Of note, an EKG done 
four days prior showed ST-elevation, though less 
pronounced (Figure 2). Chest x-ray showed bilateral lung 
nodules consistent with metastases and bilateral airspace 
disease (Figure 3). Urine drug screen was negative.
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and subsequent evaluation for local radiotherapy and 
possible chemotherapy to reduce the metastatic burden. 
The same is true for brady- or tachy-arrhythmias induced 
by cardiac metastasis, though symptoms can be mitigated 
by placement of a pacemaker or the use of anti-arrhythmic 
medication, respectively. If cardiac metastases are leading 
to coronary artery occlusion or compression causing 
ischemic symptoms, urgent surgical resection, radiation 
therapy, or coronary angiography should be considered.
KEY POINTS
• The differential for ST-elevation includes STEMI, stress 
cardiomyopathy, pericarditis, myocarditis, left 
ventricular aneurysm, coronary vasospasm, pulmonary 
embolism, the Brugada syndrome, left ventricular 
hypertrophy, left bundle branch block, early repolar-
ization, hyperkalemia, and rarely, tumor invasion of the 
heart3,4,5,6.
• The clinical context, ST morphology and distribution, 
comparison with prior EKGs and echocardiogram can 
help distinguish between etiologies of ST-elevation.
• Patients with known or suspected metastatic disease 
who present with possible ischemic heart disease or 
rhythm disturbance should undergo a prompt cardiac 
workup beginning with EKG and echocardiography, 
with further imaging if clinical suspicion of cardiac 
involvement persists.
REFERENCES
1. Heron M. Deaths: Leading Causes for 2012. National Vital Statistics Reports. 
2015;64(10):1-93.
2. Cohen M, Boiangiu C, Abidi M. Therapy for ST-segment Elevation Myocardial 
Infarction Patients Who Present Late or are Ineligible for Reperfusion Therapy. J 
Am Coll Cardiol. 2010;55(18):1895-1906.
3. Wang K, Asinger R, Marriott H. ST-Segment Elevation in Conditions Other Than 
Acute Myocardial Infarction. The New England Journal of Medicine. 2003; 
349:2128-35.
4. Chandra S, Singh S, Nehra M, Agarwal D, Singh N. ST-segment elevation in 
non-atherosclerotic coronaries: a brief overview. International Journal of 
Emergency Medicine. 2011;6(2):129-139.
5. Gu YL, Svilaas T, van der Horst ICC, Zijlstra F. Conditions mimicking acute 
ST-segment elevation myocardial infarction in patients referred for primary 
percutaneous coronary intervention. Netherlands Heart Journal. 2008; 
16(10):325-331.
6. Hanna E, Glancy DL. ST-segment elevation: Differential diagnosis, caveats. 
Cleveland Clinic Journal of Medicine. 2015;82(6):373-384.
7. Gard J, Bader W, et al. Images in Cardiovascular Medicine: Uncommon Cause of 
ST Elevation. Circulation. 2011;123:e259-e261.
8. Reynen K, Kocheritz U, Strasser RH. Metastases to the heart. Annals of Oncology. 
2004;15:275-381.
9. Goldberg AD, Blankstein R, Padera RF. Tumors metastatic to the heart. 
Circulation. 2013;128(16):1790-1794.
10. Perazzolo Marra M, Thiene G, et al. Concealed metastatic lung carcinoma 
presenting as acute coronary syndrome with progressive conduction 
abnormalities. Circulation. 2012;125:e499-e502.
11. Bussani R, De-Giorgio F, Abbate A, Silvestri F. Cardiac metastases. J Clin Pathol. 
2007;60:27-34.
12. Bruce CJ. Cardiac tumours: diagnosis and management. Heart. 2011;97:151-160.
Though often clinically insignificant, the incidence of 
cardiac involvement in patients with known malignancy is 
estimated between 9.1% – 25.0% based on current 
literature8,9. Nearly all varieties of malignancy can 
metastasize to the heart, the most common being 
primary lung cancer, primary breast cancer, hematologic 
malignancies, and malignant melanoma10. There are four 
primary pathways by which tumors can invade the heart: 
hematogenous spread, lymphatic spread, transvenous 
extension, and direct extension. 
The location of neoplastic metastasis typically dictates 
the subsequent symptomatology. The most common 
clinical manifestations of tumors extending to the 
pericardium are pericarditis and pericardial effusions, 
which can be further complicated by cardiac tamponade. 
Malignant effusions may develop insidiously or rapidly, 
and the risk of tamponade development is always present 
regardless of the size of the effusion. In addition, small 
metastases to the pericardium have rarely been shown to 
cause constrictive pericarditis10.  
The clinical picture that develops in the setting of 
pericardial involvement is distinctly different from that of 
epicardial, myocardial, or endocardial involvement. Case 
reports from the literature describe episodes of both atrial 
and ventricular arrhythmias, along with complete heart 
block due to invasion of the cardiac conduction system. 
Additionally, significant infiltration of metastatic disease 
into the coronary arteries, or extrinsic compression from 
metastases or tumor burden, can result in a clinical 
scenario mimicking acute coronary syndrome in regards 
to both patient symptoms and EKG changes8,10. 
When a patient with a known malignancy presents with 
the new onset of cardiac symptoms in the absence of 
another clear diagnosis, it is paramount to consider and 
work up the possibility of metastatic disease. EKG findings 
in metastasis to the myocardium may reveal ST-elevations 
in contiguous leads that are persistent and not evolving 
and typically are not accompanied by ST-depression in 
reciprocal leads. Furthermore, EKG involvement of the 
pericardium may show signs of low voltage or electrical 
alternans, suggesting possible effusion or diffuse ST 
elevation suggesting pericarditis10. However, more 
definitive imaging is needed to complete a metastatic 
work up. Echocardiogram will reveal the presence of 
overt cardiac masses and also pericardial effusions and 
tamponade physiology, but it should only compose part 
of the work up. Cardiac computerized tomography (CT) 
would reveal tumor extension from proximal anatomic 
sites, and coronary CT would provide evaluation of 
coronary vasculature. On positron emission tomography 
(PET), metastases will often show increased metabolic 
activity. Of note, cardiac MRI provides the best tissue 
characterization of the myocardium and is often able to 
identify metastases missed on both cardiac CT and 
echocardiography12.  
Management of these conditions depends on the clinical 
symptoms at presentation. Cardiac tamponade merits 
urgent intervention via placement of a pericardial drain 
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Figure 1. EKG from admission showing 1-5mm ST-elevations in leads V2-V6.
Figure 3. Single-view chest x-ray on admission showing multiple 
round masses within both lungs, predominantly in the lower lung 
fields. The largest measures approximately 4.6 x 2.5 cm in the 
right base.
Figure 2. EKG four days prior to admission showing less prominent ST elevations in V2-V5, compared 
to admission to EKG. Figure 4. Echocardiogram showing 2.4cm mass at left and right 
ventricular apex: parasternal long axis view. 
Figure 5. Echocardiogram showing 2.4cm mass at left and right 
ventricular apex: apical four chamber view.
Figure 6. EKG from before patient developed metastatic disease showing no ST-elevations.
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